Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2gQqN2T
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
[PDF] Καρκίνος του στομάχου -- Αλέξανδρος Γ. Σφακιανάκης Αναπαύσεως 5 Άγιος Νικόλαος Λασιθίου 72100 2841026182
-
Abstract Introduction In recent years, platelet-rich plasma (PRP) has emerged as a promising autologous biological treatment modality fo...
-
Abstract Objective We sought to validate an algorithm designed to identify patients with post-gastric bypass hypoglycemia (PGBH) using c...
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader http://bit.ly/2SljgLr
-
European Journal of Trauma and Emergency Surgery from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2mFdvGj
-
British Journal of Sports Medicine from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2lWCbgc
-
Using the Pulsara app, a Cincinnati-area health care system significantly cut down its time to treatment for cardiac cases from EMS via xl...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου